- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01134458
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes (FIMDM_CVD)
July 18, 2014 updated by: Duke University
The investigators propose an evaluation that will assess three important components of risk communication:
- provide patients with personalized risk communication using the risk calculator developed by FIMDM and health information taken from the Living with Coronary Artery Disease program
- provide personalized tailored patient feedback to help initiate and maintain specific cardiovascular CVD-related behaviors(e.g., medication adherence, exercise, diet, smoking cessation) to reduce their risks.
- evaluate how this feedback can be incorporated into clinical care by examining 3 month patient outcome and provider responses to the risk information.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Patients at high risk for CVD events frequently underestimate their risk.
Programs to improve CVD outcomes have largely focused on single risk factors and do not contextualize the information with a patient's global risk.
An easy, accessible strategy to address global CVD risk based on personalized risk communication feedback with assistance with initiating and maintaining health behaviors has several advantages, but has not formally been tested.
A patient's perceived risk of stroke or heart attack is an important factor in understanding motivation for risk reducing behaviors.
Lower perceived risk has been associated with poorer adherence to recommended health behaviors.
Additionally, a person's beliefs about his or her risk for a disease increased the likelihood of a more informed and activated patient, and figures prominently in models of health behavior (e.g., Health Belief Model).
People tend to underestimate their own risk; Therefore providing accurate risk communication has the potential to activate patients to initiate and maintain behavior changes.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- cardiovascular disease (CVD)
- CVD risk equivalent (peripheral arterial disease, history of ischemic stroke, or diabetes)
Exclusion Criteria:
- metastatic cancer,
- dementia,
- active psychosis
- end-stage renal disease
- no access to computer with Internet
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Receive primary care and management of CVD according to the discretion of their primary care provider.
They will also receive generic educational information concerning CVD at baseline and at study end (at their request).
We will collect outcomes at baseline and 3-months.
|
|
Experimental: Web-based Intervention
Given current risk assessment for CVD based on Health Dialog Cardiac Risk Calculator, recommendations for behavior change, and Health Dialog's Living with Coronary Heart Disease.
Can change initial patient risk information provided by the Risk Calculator during the initial visit, noting what they are will work on during the study.
Sent monthly email reminders to log onto the system to choose that months' behavioral modules.
Given a choice of at least 2 health behavior modules per month (smoking cessation, exercise, diet, and weight) to improve their CVD risk.
Information on risk, CVD knowledge, medication management and side effects will be provided to all participants.
It will also provide tailored information to help the individual initiate and maintain these behaviors.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiovascular Disease (CVD) Risk Knowledge Assessment
Time Frame: Baseline and 3 month @ study end
|
Trained personnel will obtain the patients' outcome values (i.e., weight, height, BP) at baseline and subsequent 3-month outcome using a digital sphygmomanometer and digital scale according to a standard protocol.
The baseline interview includes demographics and an assessment of patients' health behavior, perceived risk, and interactions with their provider.
At 3-month follow-up visit, patients will also undergo an in-person interview to determine changes in weight, smoking status, medication adherence, decisional conflict, knowledge.
|
Baseline and 3 month @ study end
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hayden Bosworth, PhD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
May 28, 2010
First Submitted That Met QC Criteria
June 1, 2010
First Posted (Estimate)
June 2, 2010
Study Record Updates
Last Update Posted (Estimate)
July 22, 2014
Last Update Submitted That Met QC Criteria
July 18, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00024341
- FIMDM Research Grant 0170-1 (Other Grant/Funding Number: Foundation for Informed Medical Decision Making, Inc)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
-
Penn State UniversityAlmond Board of California; The Hershey CompanyCompletedCardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentCompleted
-
Aziyo Biologics, Inc.CompletedCardiovascular DiseaseUnited States
-
Monash UniversityCompletedCardiovascular DiseaseAustralia
Clinical Trials on Web-Based Intervention
-
Cardenal Herrera UniversityCompleted
-
Northwestern UniversityWithdrawnIndividuals at Risk for DepressionUnited States
-
Taipei Medical UniversityRecruitingInfertility | Heart Rate Variability | BiofeedbackTaiwan
-
NYU Langone HealthStanford University; Shaare Zedek Medical CenterCompletedAnxiety Disorders | Major Depression | Post Traumatic Stress DisorderIsrael
-
Taipei Medical UniversityNot yet recruitingParenting | Psychological Distress | Self Efficacy
-
Heidelberg UniversityCompetence Network for Congenital Heart DefectsRecruitingCongenital Heart Disease | Emotional RegulationGermany
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Hong Kong Baptist UniversityCompletedPhysically Well But WorriedHong Kong
-
Georgetown UniversityAlbert Einstein College of Medicine; University of MichiganCompletedTobacco Cessation | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Virus, Human Immunodeficiency | Tobacco-Use DisorderUnited States
-
Columbia UniversityNational Institute on Aging (NIA)RecruitingHealthy AgingUnited States